Ernexa Therapeutics Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Ernexa Therapeutics Inc. (ERNA) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$181.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2011-11-14
- Ernexa Therapeutics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2011-09-30 was $26.00K.
- Ernexa Therapeutics Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2010-09-30 was -$107.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month |
|---|---|---|---|
| 2011-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$181.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$207.00K 10-Q · filed 2011-08-12 | ||
| 2010-09-30 | -$107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$241.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | -$134.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |